ID   VAO1
AC   CVCL_S601
DR   Wikidata; Q54992941
RX   Patent=US6660276;
RX   PubMed=7681084;
CC   HLA typing: A*02 (PubMed=7681084).
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
RX   Patent=US6660276;
RA   Slingluff, Craig L. Jr.
RA   Engelhard, Victor H.
RA   Hunt, Donald Frederick
RA   Shabanowitz, Jeffrey
RA   Cox, Andrea L.
RT   "Peptides recognized by melanoma-specific cytotoxic lymphocytes, and
RT   uses therefor.";
RL   Patent number US6660276, 09-Dec-2003.
//
RX   PubMed=7681084; DOI=10.4049/jimmunol.150.7.2955;
RA   Slingluff, Craig L. Jr.
RA   Cox, Andrea L.
RA   Henderson, Ralph A.
RA   Hunt, Donald Frederick
RA   Engelhard, Victor H.
RT   "Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic
RT   T lymphocytes is mediated by at least six shared peptide epitopes.";
RL   J. Immunol. 150:2955-2963(1993).
//